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regional wall motion abnormalities, in 51/65 both observers agreed on the absense of
abnormalities on the CMR study. (sensitivity 75% and specificity 78%) The lesions were
most frequently located in the septal and anterolateral wall.
Conclusions: Functional and delayed enhanced CMR enables valuable detection and
localisation of cardiac sarcoidosis.
1169-158 Magnetic Resonance Imaging Can Reliably Identify 
Heart Iron Overload in Patients With B-Thalassemia 
Major
Sophie Mavrogeni, L. Kaklamanis, D. Tsiapras, I. Paraskevaidis, G. Karavolias, V. 
Markussis, M. Karagiorga, M. Douskou, D. V. Cokkinos, D. T. Kremastinos, Onassis 
Cardiac Surgery Center, Athens, Greece
Background: Patients with b-thalassemia major depend on continuous blood transfu-
sions for survival. As a consequence, iron overload occurs in all organs including the
heart. Heart biopsy is the only way to detect heart iron deposition, but it is invasive and
not easily repeatable. We applied magnetic resonance imaging (MRI) for the assessment
of myocardial iron deposition in patients with b-thalassemia and compared the results
with cardiac biopsy data.
Methods: Twenty-five consecutive thalassemic patients, NYHA II-III, were studied using
a 0.5 T system, ECG-gated, with TE=17-68 msec. T2 relaxation time of the interventricu-
lar septum was calculated assuming simple monoexponential decay in one square centi-
meter regions of interest. Heart biopsy was performed within a week after the MRI study. 
Results: Seven of the 25 patients had heart biopsy indicative of low iron deposition
(Group A) and the remaining 18 patients had heart biopsy indicative of high iron deposi-
tion (Group B). T2 relaxation time of the heart (T2H) was in agreement with heart biopsy
in 86% of the patients in Group A vs. 78% of the patients in Group B (overall agreement
80%). Similarly, serum ferritin levels were in agreement with heart biopsy in 28% vs.
88%, respectively (overall agreement 72%). In Group A, MRI was in better agreement
with biopsy compared to ferritin (86% vs. 28%, p<0.05).
Conclusions: Heart T2 relaxation time appears in agreement with cardiac biopsy, both in
high and low iron deposition, and is a useful non-invasive index for serial evaluation in b-
thalassemia.
1169-159 Myocardial Infarct Age Determined by Contrast-
Enhanced Cine Magnetic Resonance Imaging
Gilbert L. Raff, Ralph E. Gentry, James A. Goldstein, William Beaumont Hospital, Royal 
Oak, MI
Background
In patients with acute chest pain and resting wall motion abnormalities, differentiating
acute myocardial infarction (AMI) and chronic myocardial infarction (CMI) can have
important therapeutic implications. Contrast-enhanced cine magnetic resonance imaging
(CEC) has been shown to sensitively diagnose microvascular obtruction (MO), a signa-
ture of AMI that is rarely seen in CMI. The present study was designed to determine if
CEC can distinguish between AMI and CMI.
Methods
In 43 patients with enzyme-documented AMI treated by reperfusion, we performed CEC
within 36 hours of admission, and repeated this examination after 3 months. CEC imag-
ing was performed approximately 1 minute after 0.20mmol/kg of I.V. gadolinium-DTPA
contrast. Nine 8mm short-axis slices and two long-axis slices acquired, using an-EKG
gated, segmented k-space true-FISP pulse sequence. At 10 minutes post-injection, after
an inversion time scan for optimum myocardial nulling, an inversion-recovery turbo-
FLASH delayed hyperenhancement (IR-DE) study was done in identical slices. MO was
defined as discrete endocardially-based hypoenhancing regions that became all or par-
tially enhanced on IR-DE. All studies were read by two blinded observers.
Results
Microvascular obstruction on CEC was seen in 35/43 (81%) of patients with AMI, and in
only 4/43 (9%) after 3 months. The presence of MO on CEC 81% sensitive and 91% spe-
cific for AMI.
Conclusions
The presence of microvascular obstruction on contrast-enhanced cine MRI is a sensitive
and specific predictor of acute MI. Its absence suggests chronic MI.
1169-160 Systolic and Diastolic Strain Rates by Tagged Magnetic 
Resonance Imaging Distinguishes Regions With 
Different Degrees of Myocardial Injury After Acute 
Myocardial Infarction
Clerio F. Azevedo, Luciano C. Amado, Dara L. Kraitchman, Bernhard L. Gerber, Nael F. 
Osman, Carlos E. Rochitte, Thor Edvardsen, Joao A. Lima, Johns Hopkins Hospital, 
Baltimore, MD
Background: Myocardial injury after acute myocardial infarction (AMI) is a regional and
heterogeneous process that affects both systolic and diastolic function. Using tagged
MRI, we evaluated regional systolic and diastolic function in areas with different degrees
of myocardial injury after AMI and assessed whether both measures combined would
allow us to better characterize and distinguish these regions.
Methods: Fourteen dogs underwent 90-min coronary artery occlusion followed by reper-
fusion. Five short-axis slices were acquired for each dog within the first 24h of reperfu-
sion using 3 techniques: tagged MRI, first-pass perfusion and delayed-enhancement
(DE). Regional blood flow <50% of remote by radioactive microspheres during coronary
artery occlusion was used to define risk region. Each slice was divided in 6 segments
that were classified in 4 categories: transmural AMI (DE>50% area, n=95), subendocar-
dial AMI (DE<50% area, n=82), risk region (n=80) and remote area (n=163). For each
segment, circumferential systolic strain (Ecc), systolic strain rate (SSr) and early diastolic
strain rate (DSr) were calculated.
Results: Transmural AMI segments displayed depressed systolic contractility compared
to subendocardial AMI segments (P<0.01), and both showed reduced systolic and dias-
tolic regional function compared to remote areas (Ecc = –2.5±0.5% and –6.0±0.6% ver-
sus –13.1±0.5%, SSr = –0.11±0.10s–1 and –0.82±0.12s–1 versus –2.15±0.08s–1 and
DSr = 1.26±0.09s–1 and 1.50±0.08s–1 versus 2.99±0.10s–1, for transmural and suben-
docardial AMI segments versus remote areas, P<0.001 for all). In contrast, risk region
segments only exhibited diastolic impairment (DSr=1.62±0.09s–1, P<0.001 versus
remote), but not systolic dysfunction (NS versus remote). Importantly, after controlling for
segmental infarct extension, the presence of microvascular obstruction (“no reflow”) was
related to further impairment of systolic and diastolic regional function (P<0.05 for both).
Conclusion: Regional systolic and diastolic functional assessment using strain rate
analyses provides for superior characterization and distinction of regions with different
degrees of myocardial injury after AMI.
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1170-141 Initial Results Regarding the Safety, Tolerability, and 
Hemodynamic Effects of CVT-3146, a Selective 
Adenosine A2A Agonist, in Patients Undergoing 
Pharmacologic Stress SPECT Myocardial Perfusion 
Imaging
Robert C. Hendel, John J. Mahmarian, Timothy M. Bateman, Manuel D. Cerqueira, Ami 
E. Iskandrian, Markus Jerling, Hisham Y. Abdallah, Jeffrey A. Leppo, Rush University 
Medical Center, Chicago, IL
Background: CVT-3146 is a selective A2A adenosine receptor agonist shown to induce
coronary hyperemia and potentially procude less adverse effects due to its limited stimu-
lation of receptor subtypes not involved with coronary vasodilation. Thus, CVT-3146 may
be an effective pharmacologic stress agent.
Methods: We studied 36 subjects (27 men, 9 women; 67±10 years) with two doses of
CVT-3146 [400 mcg (n=18), 500 mcg (n=18)], administered by IV bolus, as part of a
pharmacologic stress SPECT myocardial perfusion imaging protocol.
Results: Adverse effects (AE) occurred in 26 subjects (72%), including chest discomfort
(33%), headache (25%), and abdominal pain (11%), with a similar incidence for both
doses. Flushing, dyspnea, and dizziness were more frequent in the 500-mcg group
(44%, 44%, and 28%, respectively) than in the 400-mcg group (17%, 17%, and 11%,
respectively). Most AE’s were mild to moderate (96%) and resolved within 15 minutes
without treatment (91%). One serious AE occurred, with exacerbation of a migraine
headache, requiring hospitalization. ST and T wave abnormalities developed with CVT-
3146 in 7 and 5 subjects, respectively. No 2nd or 3rd degree AV block was noted and
there were no serious arrhythmias. Peak hemodynamic effects were noted at 4 minutes
for systolic blood pressure (-5.9±10.7 mmHg) and within 2 minutes for heart rate
(+21.9±10.4 beats per minute). Systolic BP did not fall below 90 mmHg with either dose.
The mean change in HR response was higher for the 500 mcg dose than for 400 mcg.
Thirty minutes after CVT-3146, BP changes deviated <2% from baseline but HR
remained above baseline by 8.6%.
Conclusion: CVT-3146 is well-tolerated and has accceptable hemodynamic effects. Mini-
mal differences were noted in BP and HR responses between the 400 mcg and 500 mcg
doses, but AE’s were more frequent at the higher dose. CVT-3146 appears safe and well-
tolerated for bolus-mediated pharmacologic stress SPECT myocardial perfusion imaging.
1170-142 Differential Vasodilatory Effects of CVT-3146, an A2A 
Adenosine Receptor Agonist in Various Vascular Beds 
in Anesthetized Dogs
Arvinder K. Dhalla, Jiang Xu, William Kussmaul, Peter P. Kurnik, Amir Pelleg, Luiz 
Belardinelli, CV Therapeutics, Inc, Palo Alto, CA, Drexel University, College of Medicine, 
Philadelphia, PA
CVT-3146 is a novel selective A2A adenosine receptor agonist being developed as a
pharmacologic stressor for radionuclide myocardial perfusion imaging. Previously it has
been shown in awake dogs that CVT-3146 causes coronary vasodilation without signifi-
cantly affecting either total peripheral resistance or renal blood flow. The goal of this
study was to determine the differential effects of CVT-3146 on blood flow velocity in vari-
ous vascular beds. The effect of CVT-3146 on the blood flow velocity in the canine left cir-
cumflex coronary artery (LCX), brain arterial vasculature (BA), forelimb artery (FA) and
pulmonary artery (PA) of comparable diameters were quantified as the average peak
blood flow velocity (APV) using intravascular Doppler transducer-tipped catheter. CVT-
3146 (1.0 µg/kg) given as an intravenous bolus, transiently enhanced blood flow which
was site specific: APV increased 3.1+0.2, 1.4+0.1, 1.2+0.1, and 1.1+ 0.01 fold in the
LCX, BA, FA and PA, respectively manifesting a site-potency rank order of LCX
>>BA>FA>PA (figure). The effect of CVT-3146 on blood flow velocity was short lasting;
reaching a peak in less than 30 sec and dissipating in less than ten minutes. Increased
blood flow velocity was associated with a small transient increase in heart rate (16 bpm)
